Arbutus Biopharma Corp (NASDAQ:ABUS)

5.50
Delayed Data
As of 4:00pm ET
 +0.05 / +0.92%
Today’s Change
3.20
Today|||52-Week Range
8.25
+8.91%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close5.45
Today’s open5.45
Day’s range5.40 - 5.68
Volume203,721
Average volume (3 months)194,896
Market cap$319.3M
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)-440.30%
Earnings growth (this year)+81.85%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-94.01%
P/E ratioNM
Price/Sales87.21
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
OVIDOvid Therapeutics In...-0.07-0.70%
CPRXCatalyst Pharmaceuti...+0.02+0.78%
DRRXDURECT Corp-0.01-0.48%
STMLStemline Therapeutic...+0.15+0.90%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 16, 2018
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$1.5M
Annual profit (last year)-$384.2M
Net profit margin-25,765.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer
Koert VandenEnden
Corporate headquarters
Burnaby, British Columbia

Forecasts